Self Care Catalysts has launched a collaboration with Roche through the Roche COVID-19 Data Science Coalition project. The initiative will use Self Care Catalysts’ Health Storylines as the offiicial COVID-19 app that will collect data from the community.

Zucara Therapeutics Inc. has announced that it has closed a US$21 million Series A Financing led by Perceptive Xontogeny Venture Fund.

VBI Vaccines has announced a collaboration with the NRC to develop a pan-coronavirus vaccine candidate, targeting COVID-19, SARS, MERS.

The Government of Canada has announced a series of measures to help businesses as they respond to COVID-19.

RBC Healthcare has partnered with four health care tech companies, including CoHealth, on a new package of services to help physicians establish and manage their practices.

CB Insights recently released its annual list of most promising AI start-ups in the world. This year’s list included health care companies Cyclica and ProteinQure.

ToeFX will begin clinical trials of its light therapy to treat onychomycosis, a fungal infection of the nail.

AMGEN BIONATION Regenerative Medicine Innovation Challenge 2020 Announces Call for Applications

Conavi Medical Inc. has received regulatory approval from the Japanese health ministry for its Novasight Hybrid™ intravascular imaging system.

The Weston Brain Institute is accepting applications for its research grant programs supporting translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging.

Stem Cell Network announces funding competition for stem-cell based technologies or therapies

University of Toronto professor elected as an international member of the U.S. National Academy of Engineering (NAE).

Toronto Rehab Foundation, in partnership with KITE Research Institute, is hosting the second Power Play Pitch Competition.

XPan Inc. and Nanology Labs receive new follow-on investments from FACIT.

VoxNeuro’s Cognitive Health Assessments™ will be used alongside blood tests and various behavioural and clinical assessments to identify biomarkers of bipolar disorder.

VBI Vaccines, a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, has reported that the Phase 3 study of its trivalent hepatitis B vaccine has met both primary and secondary endpoints for safety and efficacy.

The Trade Commissioner Service is currently recruiting for the Canadian Technology Accelerator cohort for life sciences start-ups and companies seeking to expand in the US and Asia.

Toronto-based Deep Genomics, which has developed a platform that uses deep learning to create therapies, has closed a $40 million Series B round.

ProteinQure, which has designed a platform to automate the computational design of protein-based drugs, has been named one of CB Insights’ Game Changers for 2020.

Synaptive Medical, a Toronto-based medical and technology company solving surgical, imaging and data challenges, has completed a first round of investment totaling $25,000,000 USD.